FEF inactivation alters WM behavioral performance and phase coding in visual areas.
A) V4 recordings were made before and after infusion of muscimol into FEF. Muscimol injections into FEF were made with a custom microinjectrode, at sites with stimulation-evoked saccade endpoints overlapping with simultaneous V4 recording site RFs.
B) Eye traces for 8 MGS target locations, before (left) and after (right) FEF inactivation, for an example session where 0.5 microliter of muscimol was injected into the FEF; performance deficits were localized to the infusion hemifield.
C) Average behavioral performance across sessions, at different locations over time following FEF inactivation (red pre-inactivation; green, blue, and black, 1, 2, and 3 hours after inactivation, respectively). Data from each session is aligned so that 0 degrees corresponds to the FEF RF.
D-E) Normalized saccade error (D) and reaction times (E) for the memory IN (red) and OUT (black) conditions, over time relative to the FEF inactivation. Black bar indicates times with a significant difference between IN and OUT. Shaded areas show SEM across sessions.
F) Heatmap shows phase coding (MI, colorbar) over time and frequency for 66 V4 neurons, for the IN condition, before (left) and after (right) FEF inactivation. Black rectangle indicates time and frequency range considered in (G-H): 14-22Hz, 200-800ms after start of delay period.
G) Strength of β phase coding over time, for memory IN, before (red) and after inactivation (blue). The phase-code MI is averaged in the β range. Shading shows SEM across neurons. Gray area indicates time window plotted in (H).
H) Scatter plot of β phase MI during the delay period (shaded area in G) of the IN condition for each V4 neuron, before vs. after FEF inactivation. Red square shows population mean. The histogram in the upper right shows the distribution of difference in MI (Pre-Post) across neurons. (*, p <0.05; **, p <0.01; ***, p <0.001; ns, p>0.05)